Posted On: 03/04/2015 7:00:14 PM
Post# of 30067
Re: Stoicinvestor #17593
I'm not completely clear on what you're saying, but if your referencing the arrow that had crossed the "commercialization box", then yes LymPro entered that box for the IUo market.
As for a "commercial DX"
GC said in the January presentation that "MSPrecise is our lead commercial diagnostic via CLIA in 2015"
LymPro intinal target market is $150mm for IUO
Upcoming Milestones for LymPro are
1) First pharmaceutical Biomarker customer sales
2) CLIA Certification
3) CE Mark
4) FDA Pathway evaluation
So, again, I don't understand what you're pointing out.
Cheers
As for a "commercial DX"
GC said in the January presentation that "MSPrecise is our lead commercial diagnostic via CLIA in 2015"
LymPro intinal target market is $150mm for IUO
Upcoming Milestones for LymPro are
1) First pharmaceutical Biomarker customer sales
2) CLIA Certification
3) CE Mark
4) FDA Pathway evaluation
So, again, I don't understand what you're pointing out.
Cheers
(0)
(0)
